Evaluating PFAS Testing Methods and Workflow Tradeoffs

PFAS testing is often framed as an instrument question, but the more consequential choice is the analytical question itself. A laboratory may need a defensible concentration for a defined list of compounds, a broad indication that organofluorine is present, or evidence that unknown fluorinated substances warrant further investigation. Each objective points to a different workflow, quality-control burden, and interpretation.

The United States Environmental Protection Agency has validated methods for specific matrices and programs. EPA Methods 533 and 537.1 support regulated drinking-water monitoring. Method 1633A addresses 40 PFAS in aqueous, solid, biosolid, tissue, and related environmental matrices. Method 8327 covers 24 PFAS in non-drinking-water aqueous samples under the SW-846 framework. Method 1621 measures adsorbable organic fluorine, or AOF, as a method-defined aggregate signal. High-resolution mass spectrometry can extend a project into suspect screening and non-target analysis, but it does not turn an unidentified feature into a quantified regulatory result.

Start With the Decision, Not the Instrument

A defensible method-selection memo can begin with four questions. If any answer remains vague, the project is not ready for a final analytical scope.

This sequence prevents a common error: selecting a familiar LC-MS/MS method and later discovering that its validated matrix, analyte list, or required quality controls do not match the project. LabPress’s guide to choosing sample preparation for environmental LC-MS explains how recovery and matrix effects enter this decision. The overview of what laboratories need for EPA Method 1633A covers the method’s infrastructure and contamination-control implications.

Compare the Main PFAS Analytical Paths

Instrument capacity still matters after the analytical path is chosen. A triple-quadrupole LC-MS/MS system supports sensitive targeted quantitation and multiple-reaction monitoring, while an accurate-mass system supports broader feature detection and retrospective review. The relevant purchasing question is not which platform has the longest specification list, but whether the laboratory can sustain the chosen method’s sensitivity, calibration, cleanup, throughput, data review, and service requirements. LabPress’s buyer’s guide to LC-MS systems for regulated quality-control laboratories provides a practical framework for those instrument-level checks.

Build the Workflow Around Contamination and Recovery

PFAS are measured at low concentrations and can appear in laboratory and sampling materials. That makes blanks and materials review part of the measurement system rather than an administrative afterthought. At the same time, a blanket ban on every fluorinated consumer item can distract from the contamination pathways that the project can actually document.

Sampling and Receipt

Use the container, preservation, collection, and holding-time requirements in the selected method or program. Define field blanks, equipment blanks, and duplicate locations before sampling. Record sample condition, container type, volume, temperature, and deviations at receipt. For matrices with suspended solids, confirm whether the method treats the sample as a whole or allows a separated fraction. A filtered result and a whole-sample result can support different interpretations.

Extraction and Cleanup

Match extraction to matrix load. Drinking-water SPE procedures are not automatically appropriate for wastewater with suspended solids or organic matter. EPA specifically notes that Methods 533 and 537.1 were evaluated for drinking water and do not contain the mandatory cleanup steps in Method 1633A for many wastewater samples. When a laboratory offers a “modified” drinking-water method for another matrix, obtain the laboratory SOP and supporting performance data rather than assuming equivalence.

Calibration and Batch Quality Control

Confirm which analytes use isotope dilution, extracted internal standards, surrogates, or external calibration. Review initial and ongoing calibration, blanks, laboratory control samples, matrix spikes, duplicates, and the method’s acceptance criteria as a connected batch. One passing spike does not erase a contaminated blank, severe matrix suppression, or carryover after a high sample.

Data Review

Require the laboratory to report the method version, preparation procedure, target list, reporting limits, qualifiers, dilution factors, and QC exceptions. EPA’s technical brief on PFAS data review emphasizes that protocols, QC criteria, and review practices vary. A project data package should make those differences visible enough for the data user to judge comparability.

Common Failure Modes and Corrective Questions

Using a Drinking-Water Method for Wastewater Without a Defensible Basis

Ask: Which parts of the published method changed, why were they changed, and what matrix-specific recovery, precision, blank, and interference data support the laboratory SOP?

Treating a Non-Detect as Proof of No PFAS

A targeted method can only address the compounds on its list at the achieved reporting limits. Ask: Was the decision limited to those targets, or does the project also need AOF, suspect screening, or another line of evidence?

Comparing Results From Different Fractions or Preparations

Filtered water, whole water, extractable material, and total-sample preparations are not automatically comparable. Ask: Were matrix definition, solids handling, sample volume, cleanup, and units aligned before trend analysis?

Allowing High Samples to Contaminate the Sequence

Carryover can turn a real high-concentration sample into false low-level detections in later injections. Ask: What rinse, blank, reinjection, dilution, and sequence rules apply after a high result?

Overstating an HRMS Identification

A formula, suspect match, and confirmed compound are different evidence levels. Ask: Was the feature confirmed with retention time, fragmentation, and an authentic standard, and is any concentration reported as quantitative or estimated?

Ignoring Branched and Linear Isomers

Some PFAS occur as mixtures of isomers that may not be resolved or integrated identically across methods. Ask: How does the method define integration and reporting for branched and linear forms, and is that treatment consistent across the data set?

Illustrative Example: Investigating a Wastewater Treatment Gap

A manufacturing site sees intermittent PFAS detections in final effluent and needs to determine whether treatment performance, an upstream process change, or an unmeasured fluorinated source explains the pattern.

1. Define the decision. The first question is whether the permit target list is being met. The second is whether the known targets explain most of the fluorinated burden.
2. Use a matrix-appropriate targeted method. Method 1633A is selected for influent, intermediate, and effluent samples because the project includes wastewater and requires a 40-compound target profile with isotope-dilution QC.
3. Add source-location controls. Field blanks, equipment blanks, duplicates, and sampling points around individual process streams are planned before collection.
4. Compare mass patterns, not just single concentrations. The team reviews target distributions, flow data, solids handling, blank performance, and treatment-stage changes. It does not infer removal from concentration alone when flow or phase partitioning changed.
5. Use an aggregate screen if the decision needs it. Method 1621 AOF is added to assess whether a broader organofluorine signal remains. The result is interpreted as method-defined AOF, not as total PFAS or a sum of named compounds.
6. Escalate selectively. If AOF and targeted results remain materially different, stored extracts or new samples may enter HRMS suspect screening. Candidates are prioritized for confirmation instead of being reported as fully identified from exact mass alone.

This staged design controls cost and interpretive risk. It keeps the compliance question tied to the required targeted evidence while reserving broader tools for the source-investigation question they can actually answer.

Actionable PFAS Method-Selection Checklist

• State the regulatory, operational, or research decision.
• Define every matrix and whether solids are included.
• List required targets, aggregate measures, or discovery goals.
• Confirm the exact method and version.
• Verify method status for the applicable program and jurisdiction.
• Set project reporting limits and data-quality objectives.
• Document container, preservation, holding time, and shipment rules.
• Plan field blanks, equipment blanks, and duplicates.
• Review extraction, cleanup, and sample-fraction decisions.
• Confirm isotope-labeled standard and calibration strategy.
• Set carryover and high-sample dilution rules.
• Define matrix-spike, duplicate, and batch acceptance review.
• Require qualifiers and deviations in the final data package.
• Separate targeted quantitation from aggregate and HRMS evidence.
• Record the rationale for any modified or laboratory-specific SOP.
• Predefine how discrepant results will trigger reanalysis or follow-up.

Sources and Further Reading

• U.S. EPA, EPA PFAS Drinking Water Laboratory Methods.
• U.S. EPA, Clean Water Act Analytical Methods for PFAS, including Methods 1633A and 1621.
• U.S. EPA, SW-846 Test Method 8327.
• U.S. EPA, PFAS Analytical Methods Development and Sampling Research.
• U.S. EPA, Reviewing PFAS Analytical Methods Data for Environmental Samples.
• National Institute of Standards and Technology, How Do You Measure PFAS?.

Which PFAS workflow decision creates the most uncertainty for your team: matrix selection, reporting limits, blank control, target coverage, or interpreting the gap between targeted and aggregate results?